Issue Brief: Psychiatric Pharmacists Add Value To The Interprofessional Patient Care Team

Download this issue brief as a PDF to save and print.

References are located at the bottom of this page.

References

  1. Substance Abuse and Mental Health Services Administration. (2024). Key substance use and mental health indicators in the United States: Results from the 2023 National Survey on Drug Use and Health (HHS Publication No. PEP24-07-021, NSDUH Series H-59). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/report/2023-nsduh-annual-national-report
  2. Dopheide JA, Werremeyer A, Haight RJ, Gutierrez CA, Williams AM. Positioning psychiatric pharmacists to improve mental health care. Ment Health Clin. 2022;12(2):77- 85. DOI: 10.9740/mhc.2022.04.077. PubMed PMID: 35582321; PubMed Central PMCID: PMC9009818.
  3. Werremeyer A, Bostwick J, Cobb C, Moore TD, Park SH, Price C, et al. Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders. Ment Health Clin. 2020;10(6):358-380. DOI: 10.9740/mhc.2020.11.358. PubMed PMID: 33224694; PubMed Central PMCID: PMC7653731.
  4. Cobb CD. Optimizing medication use with a pharmacist-provided comprehensive medication management service for patients with psychiatric disorders. Pharmacotherapy. 2014;34(12):1336-40. DOI: 10.1002/phar.1503. PubMed PMID: 25329409.
  5. Cobb CD, Puzantian T, Shuman M. Board-Certified Psychiatric Pharmacists and Their Potential Role in Addressing Behavioral Health Workforce Shortages. PS. 2024;75(10):1039- 1041. DOI: 10.1176/appi.ps.20230303. PubMed PMID: 38532688.
  6. AAPP Issue Brief: Addressing the Treatment Gap for Opioid and Substance Use Disorders [Internet]. [cited 2021 Oct 20]. American Association of Psychiatric Pharmacists. Available from: https://aapp.org/advocacy/sud